Brendan M. O'Malley - 20 Sep 2021 Form 3 Insider Report for ABEONA THERAPEUTICS INC. (ABEO)

Role
SVP, General Counsel
Signature
/s/ Brendan O'Malley
Issuer symbol
ABEO
Transactions as of
20 Sep 2021
Net transactions value
$0
Form type
3
Filing time
22 Sep 2021, 17:34:59 UTC
Next filing
08 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ABEO Common stock 137,454 20 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ABEO Stock Option (right to buy) 20 Sep 2021 Common stock 55,000 $1.15 Direct F2
holding ABEO Stock Option (right to buy) 20 Sep 2021 Common stock 50,000 $1.15 Direct F3
holding ABEO Stock Option (right to buy) 20 Sep 2021 Common stock 100,000 $2.34 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 130,113 shares of unvested restricted stock, which will vest on various dates between September 30, 2021 and March 1, 2025.
F2 The options vest 25% on May 31, 2020, and in 36 equal monthly installments thereafter.
F3 The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter.
F4 The options vest 25% on March 1, 2022, and in 36 equal monthly installments thereafter.